| Literature DB >> 35089926 |
Andreas G Chiocchetti1, Afsheen Yousaf1, Regina Waltes1, Anka Bernhard1, Anne Martinelli1, Katharina Ackermann1, Denise Haslinger1, Björn Rotter2, Nico Krezdorn2, Kerstin Konrad3,4, Gregor Kohls3, Agnes Vetro5, Amaia Hervas6, Aranzazu Fernández-Rivas7, Christine M Freitag1.
Abstract
Conduct Disorder (CD) is an impairing psychiatric disorder of childhood and adolescence characterized by aggressive and dissocial behavior. Environmental factors such as maternal smoking during pregnancy, socio-economic status, trauma, or early life stress are associated with CD. Although the number of females with CD is rising in Western societies, CD is under-researched in female cohorts. We aimed at exploring the epigenetic signature of females with CD and its relation to psychosocial and environmental risk factors. We performed HpaII sensitive genome-wide methylation sequencing of 49 CD girls and 50 matched typically developing controls and linear regression models to identify differentially methylated CpG loci (tags) and regions. Significant tags and regions were mapped to the respective genes and tested for enrichment in pathways and brain developmental processes. Finally, epigenetic signatures were tested as mediators for CD-associated risk factors. We identified a 12% increased methylation 5' of the neurite modulator SLITRK5 (FDR = 0.0046) in cases within a glucocorticoid receptor binding site. Functionally, methylation positively correlated with gene expression in lymphoblastoid cell lines. At systems-level, genes (uncorr. P < 0.01) were associated with development of neurons, neurite outgrowth or neuronal developmental processes. At gene expression level, the associated gene-networks are activated perinatally and during early childhood in neocortical regions, thalamus and striatum, and expressed in amygdala and hippocampus. Specifically, the epigenetic signatures of the gene network activated in the thalamus during early childhood correlated with the effect of parental education on CD status possibly mediating its protective effect. The differential methylation patterns identified in females with CD are likely to affect genes that are expressed in brain regions previously indicated in CD. We provide suggestive evidence that protective effects are likely mediated by epigenetic mechanisms impairing specific brain developmental networks and therefore exerting a long-term effect on neural functions in CD. Our results are exploratory and thus, further replication is needed.Entities:
Mesh:
Year: 2022 PMID: 35089926 PMCID: PMC8797262 DOI: 10.1371/journal.pone.0261691
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary descriptive table by group.
| TD controls | CD-cases | p overall | |
|---|---|---|---|
| N = 50 | N = 49 | ||
| Recruiting center | 0.164 | ||
| Frankfurt (DE) | 24 (48.0%) | 13 (26.5%) | |
| Aachen (DE) | 9 (18.0%) | 17 (34.7%) | |
| Barcelona (ES) | 5 (10.0%) | 8 (16.3%) | |
| Bilbao (ES) | 6 (12.0%) | 6 (12.2%) | |
| Szeged (HU) | 6 (12.0%) | 5 (10.2%) | |
| Age (years) | 16.1 (1.60) | 15.8 (1.49) | 0.404 |
| Number of CD symptoms | 0.00 (0.00) | 4.76 (2.50) | <0.001 |
| Pubertal Status | 0.170 | ||
| Late pubertal | 35 (70.0%) | 41 (83.7%) | |
| Post pubertal | 15 (30.0%) | 8 (16.3%) | |
| Cigarettes per day | 0.52 (2.08) | 6.14 (6.57) | <0.001 |
| Contraceptives | 0.025 | ||
| no | 40 (80.0%) | 28 (57.1%) | |
| yes | 10 (20.0%) | 21 (42.9%) | |
| History of int. disorder | <0.001 | ||
| no | 45 (90.0%) | 20 (40.8%) | |
| yes | 5 (10.0%) | 29 (59.2%) | |
| Current medication | 0.001 | ||
| no | 47 (94.0%) | 32 (65.3%) | |
| yes | 3 (6.00%) | 17 (34.7%) | |
| Maternal smoking during pregnancy | 0.071 | ||
| no | 39 (81.2%) | 24 (61.5%) | |
| yes | 9 (18.8%) | 15 (38.5%) | |
| Maternal exp. of aggression during pregnancy | 0.001 | ||
| no | 47 (97.9%) | 30 (71.4%) | |
| yes | 1 (2.08%) | 12 (28.6%) | |
| Difficult family situation score (FamScore) | 0.20 (0.49) | 0.76 (0.80) | <0.001 |
| Parental Education (ISCED; EduPar) | 8.11 (2.66) | 5.94 (2.62) | <0.001 |
| Number of experienced traumata | 0.86 (1.11) | 2.16 (1.83) | <0.001 |
| DNA quality (260/280) ratio | 1.84 (0.02) | 1.84 (0.02) | 0.748 |
| Time to DNA purification (days) | 4.34 (3.01) | 4.02 (3.38) | 0.620 |
| Total reads per sample after cleaning | 11,017,072 (5505663) | 9,475,335 (4256539) | 0.122 |
| Population Structure | N = 49 | N = 47 | |
| PC-1 | 0.00 (0.02) | 0.00 (0.02 | 0.575 |
| PC-2 | -0.01 (0.01) | 0.00 (0.02 | 0.010 |
| PC-3 | 0.00 (0.01) | 0.00 (0.03) | 0.667 |
| PC-4 | 0.00 (0.02) | 0.00 (0.02) | 0.828 |
a) Chi2 test
b) ANOVA
c) Internalizing disorder including depression, disruptive mood dysregulation disorder, anxiety or obsessive-compulsive disorder
d) PC: Principal component of common genetic variation; data was accessible for 96 individuals
Fig 1Differentially methylated loci.
A) Hypermethylation of tag 134778 in 49 cases versus 50 controls. (log2FC -1.13 SE: 0.20 FDR = 0.0046). Log transformed number of unmethylted tags per million reads (log (tpm +1)) measures the number of un-methylated CCGG CpG regions. Thus, decreased log(tpm+1) counts indicate an increase in methylation in cases. B) tag_134778 maps to an intergenic region on chr 13 q31.3 upstream of the miRNA gene 4500HG (- coded) and the SLITRK5 gene (+ coded) within the CpG island 92. log2FC values and corresponding–log10 (uncorr P-values) are shown for the adjacent region. C) mRNA expression levels of the two adjacent genes (log2FC against mean expression) correlated against the observed normalized and log transformed read counts of the SLITRK5 methylation site for 21 available lymphoblastoid cell lines. cor.: Spearman correlation; case vs control comparison Wilcoxon-test.
Fig 2Enrichment analyses.
A) GO-term enrichment analysis: Differentially methylated regions were mapped to respective RefSeq annotated genes using the gprofiler2 algorithm accounting for the topology of GO-terms. Top 15 significant findings for GO-biological processes are shown, for full table of results see S2 Table. Correction for multiple testing is inherent to the used algorithm. B) Enrichment tests of differentially methylated loci within annotated functional genomic regions. C) Enrichment of adjacent genes among developmental brain transcriptome networks: Kang et al (2010) [44] have identified 29 distinct co-regulated gene networks that are activated during brain development and ageing. We tested the list of differentially methylated genes for enrichment in any of the 29 modules using Fisher-exact test correcting for multiple testing and identified significant overlap with modules 2 and 15 as well as among genes expressed during brain development. D) Normalized Eigenvalue plots of the two modules enriched for tags across time and brain regions. Annotated function is as published in the original paper41. Module M2 is activated during the late prenatal brain development in cortical areas and specifically in the amygdala and hippocampus. During later development the other brain areas follow. After puberty, the brain modules are constant. M15 is downregulated in the cerebellum during development and perinatally activated in the medio dorsal nucleus of the thalamus, hippocampus, amygdala, and striatum until early childhood. M15 gets activated in the other brain areas during late childhood, early puberty. Abbreviations: OFC: Orbital Prefrontal Cortex; DFC: Dorsolateral Prefrontal Cortex; VFC: Ventrolateral Prefrontal Cortex; MFC: Medial Prefrontal Cortex; M1C: Primary Motor Cortex; S1C: Primary Somatosensory Cortex; IPC: Posterior Inferior Parietal Cortex; A1C: Primary Auditory Cortex, STC: Superior Temporal Cortex; ITC: Inferior Temporal Cortex; V1C: Primary Visual Cortex; HIP: Hippocampus; AMY: Amygdala; STR: Striatum; MD: Mediodorsal Nucleus of the Thalamus; CBC: Cerebellar Cortex.